U.S. And Japan Platelet Rich Plasma Market Size, Share & Trends Analysis Report By Type, (Pure Platelet Rich Plasma, Leukocyte Rich Platelet Rich Plasma), By Application, By End-use, By Country, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1 Methodology And Scope
                   1.1 Market Segmentation
                       1.1.1 Regional Scope
                       1.1.2 Market Definitions
                       1.1.3 Estimates And Forecast Timeline
                   1.2 Objectives
                       1.2.1 Objective - 1
                       1.2.2 Objective - 2
                       1.2.3 Objective - 3
                   1.3 Research Methodology
                   1.4 Information Procurement
                       1.4.1 Purchased Database
                       1.4.2 Gvr’s Internal Database
                       1.4.3 Secondary Sources
                       1.4.4 Primary Research
                       1.4.5 Details Of Primary Research
                   1.5 Information Or Data Analysis
                       1.5.1 Data Analysis Models
                   1.6 Market Formulation & Validation
                   1.7 Model Details
                       1.7.1 Commodity Flow Analysis
                           1.7.1.1 Approach 1: Commodity Flow Approach
                           1.7.1.2 Approach 2: Country Wise Market Estimation Using Bottom-Up Approach
                   1.8 List Of Secondary Sources
                   1.9 List Of Abbreviations
Chapter 2 Executive Summary
                   2.1 Market Snapshot
                   2.2 Type And Application Segment Snapshot
                   2.3 End-Use Segment Snapshot
                   2.4 Competitive Landscape Snapshot
Chapter 3 U.S. And Japan Platelet Rich Plasma Market Variables, Trends, And Scope
                   3.1 U.S. And Japan Platelet Rich Plasma Market Lineage Outlook
                       3.1.1 Parent Market Outlook
                       3.1.2 Ancillary Market
                   3.2 Market Dynamics
                       3.2.1 Market Driver Analysis
                           3.2.1.1 Rise In Incidence Of Orthopedic Disorders And Sports Injuries
                           3.2.1.2 Increasing Cosmetic Surgeries
                           3.2.1.3 Expanding Medical Applications Of Prp
                           3.2.1.4 Increasing Evidence-Based Studies For Prp-Based Wound Healing
                       3.2.2 Market Restraint Analysis
                           3.2.2.1 High Costs Associated With Prp Products
                   3.3 U.S. And Japan Platelet Rich Plasma Market Analysis Tools
                       3.3.1 Porter's Five Forces Analysis
                       3.3.2 Pestle Analysis
                       3.3.3 Key Opinion Perspective Analysis
                       3.3.4 Market Opportunity Analysis
                       3.3.5 Buyer Perception Studies
                       3.3.6 Key Opinion Perspective Analysis
Chapter 4 U.S. And Japan Platelet Rich Plasma Market - Segment Analysis, By Type, 2018 - 2030 (USD Million)
                   4.1 U.S. And Japan Platelet Rich Plasma (Prp) Market: Type Movement Analysis
                       4.1.1 Pure Prp
                           4.1.1.1 Orthopedics
                               4.1.1.1.1 Sports Medicine
                               4.1.1.1.2 Spine
                               4.1.1.1.3 Trauma
                               4.1.1.1.4 Foot And Ankle
                               4.1.1.1.5 Joint Reconstruction
                       4.1.2 Leukocyte-Rich Rich Prp
                           4.1.2.1 Orthopedics
                               4.1.2.1.1 Sports Medicine
                               4.1.2.1.2 Spine
                               4.1.2.1.3 Trauma
                               4.1.2.1.4 Foot And Ankle
                               4.1.2.1.5 Joint Reconstruction
                       4.1.3 Others
                           4.1.3.1 Orthopedics
                               4.1.3.1.1 Sports Medicine
                               4.1.3.1.2 Spine
                               4.1.3.1.3 Trauma
                               4.1.3.1.4 Foot And Ankle
                               4.1.3.1.5 Joint Reconstruction
Chapter 5 U.S. And Japan Platelet Rich Plasma Market - Segment Analysis, By Application, 2018 - 2030 (USD Million)
                   5.1 U.S. And Japan Platelet Rich Plasma (Prp) Market: Application Movement Analysis
                       5.1.1 Orthopedics
                           5.1.1.1 Sports Medicine
                           5.1.1.2 Spine
                           5.1.1.3 Trauma
                           5.1.1.4 Foot And Ankle
                           5.1.1.5 Joint Reconstruction
                       5.1.2 Others
Chapter 6 U.S. And Japan Platelet Rich Plasma Market - Segment Analysis, By End Use, 2018 - 2030 (USD Million)
                   6.1 U.S. And Japan Platelet Rich Plasma (Prp) Market: End-Use Movement Analysis
                       6.1.1 Hospitals
                       6.1.2 Clinics
                       6.1.3 Others
Chapter 7 U.S. And Japan Platelet Rich Plasma (Prp) Market: Country Estimates And Trend Analysis
                   7.1. U.S.
                       7.1.1 Key Country Dynamics
                       7.1.2 U.S. Platelet Rich Plasma (Prp) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                       7.1.3 Competitive Scenario
                       7.1.4 Regulatory Framework
                       7.1.5 Reimbursement Scenario
                       7.1.6 Japan
                           7.1.6.1 Key Country Dynamics
                           7.1.6.2 Japan Platelet Rich Plasma (Prp) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                           7.1.6.3 Competitive Scenario
                           7.1.6.4 Regulatory Framework
                           7.1.6.5 Reimbursement Scenario
Chapter 8 Competitive Landscape
                   8.1 Company Categorization
                   8.2 Participants’ Overview
                   8.3 Financial Performance
                   8.4 Product Benchmarking
                   8.5 Company Market Share Analysis, 2023
                   8.6 Strategy Mapping
                       8.6.1 Expansion
                       8.6.2 Collaborations
                       8.6.3 New Product Launches
                       8.6.4 Acquisitions
                       8.6.5 Others
                   8.7 List Of Emerging Companies
                       8.7.1 Johnson & Johnson Services, Inc.
                       8.7.2 Arthrex, Inc.
                       8.7.3 EmCyte Corporation
                       8.7.4 Dr. PRP USA LLC
                       8.7.5 Juventix Regenerative Medical, LLC
                       8.7.6 Terumo Corporation
                       8.7.7 Zimmer Biomet
                       8.7.8 Stryker
                       8.7.9 Apex Biologix
                       8.7.10 Celling Biosciences, Inc.
                       8.7.11 Factor Medical, Inc.
                       8.7.12 CAREstream America
                       8.7.13 Royal Biologics.
Chapter 9 Conclusion

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 Growth factors involved in stages of wound healing
Table 4 Growth factors involved in wound healing with their origin
Table 5 Use of PRP in wound management
Table 6 Randomized controlled trials: PRP-based wound healing
Table 7 Some of the prominent manufacturers operating in pure PRP market
Table 8 Some of the hospitals offering PRP treatment for different applications
Table 9 Some of the PRP service providers in Japan
Table 10 Key companies undergoing expansions
Table 11 Key companies undergoing collaborations
Table 12 Key companies undergoing new product launches
Table 13 Key companies undertaking acquisitions
Table 14 Key companies undertaking other activities
Table 15 Key companies undertaking other activities
Table 16 China immunohistochemistry market, by type, 2018 - 2030 (USD Million)
Table 17 China immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 18 China immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 19 Japan immunohistochemistry market, by type, 2018 - 2030 (USD Million)
Table 20 Japan immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 21 Japan immunohistochemistry market, by end use, 2018 - 2030 (USD Million)  

List of Figures

Fig. 1 U.S. and Japan Platelet rich plasma market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Type and application segment snapshot
Fig. 10 End-use segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Global platelet rich plasma (PRP) market value, 2023 (USD Million)
Fig. 13 Market dynamics
Fig. 14 Prevalence rate of arthritis in the U.S. adults, diagnosed and projected cases
Fig. 15 Incidence of arthritis in U.S., by age
Fig. 16 Benefits of PRP treatment in cosmetic facial procedures
Fig. 17 Common minimal invasive procedures in 2019, U.S.
Fig. 18 Porter's five forces analysis
Fig. 19 PESTLE analysis
Fig. 20 Platelet rich plasma market: End-use outlook and key takeaways
Fig. 21 U.S. and Japan Platelet rich plasma (PRP) market: Type movement analysis
Fig. 22 Pure PRP market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Platelet Rich Plasma (PRP) market estimates and forecast for orthopedics, 2018 - 2030 (USD Million)
Fig. 24 Platelet Rich Plasma (PRP) market estimates and forecast for sports medicine, 2018 - 2030 (USD Million)
Fig. 25 Platelet Rich Plasma (PRP) market estimates and forecast for spine, 2018 - 2030 (USD Million)
Fig. 26 Platelet Rich Plasma (PRP) market estimates and forecast for trauma, 2018 - 2030 (USD Million)
Fig. 27 Platelet Rich Plasma (PRP) market estimates and forecast for foot and ankle, 2018 - 2030 (USD Million)
Fig. 28 Platelet Rich Plasma (PRP) market estimates and forecast for joint reconstruction, 2018 - 2030 (USD Million)
Fig. 29 Leukocyte-rich PRP market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Platelet Rich Plasma (PRP) market estimates and forecast for orthopedics, 2018 - 2030 (USD Million)
Fig. 31 Platelet Rich Plasma (PRP) market estimates and forecast for sports medicine, 2018 - 2030 (USD Million)
Fig. 32 Platelet Rich Plasma (PRP) market estimates and forecast for spine, 2018 - 2030 (USD Million)
Fig. 33 Platelet Rich Plasma (PRP) market estimates and forecast for trauma, 2018 - 2030 (USD Million)
Fig. 34 Platelet Rich Plasma (PRP) market estimates and forecast for foot and ankle , 2018 - 2030 (USD Million)
Fig. 35 Platelet Rich Plasma (PRP) market estimates and forecast for joint reconstruction , 2018 - 2030 (USD Million)
Fig. 36 Others PRP market estimates and forecast for others, 2018 - 2030 (USD Million)
Fig. 37 U.S. and Japan Platelet Rich Plasma (PRP) market estimates and forecast for orthopedics, 2018 - 2030 (USD Million)
Fig. 38 U.S. and Japan Platelet Rich Plasma (PRP) market estimates and forecast for sports medicine, 2018 - 2030 (USD Million)
Fig. 39 U.S. and Japan Platelet Rich Plasma (PRP) market estimates and forecast for spine, 2018 - 2030 (USD Million)
Fig. 40 U.S. and Japan Platelet Rich Plasma (PRP) market estimates and forecast for trauma, 2018 - 2030 (USD Million)
Fig. 41 U.S. and Japan Platelet Rich Plasma (PRP) market estimates and forecast for foot and ankle, 2018 - 2030 (USD Million)
Fig. 42 U.S. and Japan Platelet Rich Plasma (PRP) market estimates and forecast for joint reconstruction, 2018 - 2030 (USD Million)
Fig. 43 U.S. and Japan Platelet rich plasma (PRP) market: Application outlook and key takeaways
Fig. 44 U.S. and Japan Platelet rich plasma (PRP) market: Application movement analysis
Fig. 45 Platelet Rich Plasma (PRP) market estimates and forecast for orthopedics, 2018 - 2030 (USD Million)
Fig. 46 Platelet Rich Plasma (PRP) market estimates and forecast for sports medicine, 2018 - 2030 (USD Million)
Fig. 47 Platelet Rich Plasma (PRP) market estimates and forecast for spine, 2018 - 2030 (USD Million)
Fig. 48 Platelet Rich Plasma (PRP) market estimates and forecast for trauma, 2018 - 2030 (USD Million)
Fig. 49 Platelet Rich Plasma (PRP) market estimates and forecast for foot and ankle, 2018 - 2030 (USD Million)
Fig. 50 Platelet Rich Plasma (PRP) market estimates and forecast for joint reconstruction, 2018 - 2030 (USD Million)
Fig. 51 Platelet Rich Plasma (PRP) market estimates and forecast for others, 2018 - 2030 (USD Million)
Fig. 52 Percentage of adult population dental clinic visits, U.S.
Fig. 53 U.S. and Japan Platelet rich Plasma (PRP) market: End-use outlook and key takeaways
Fig. 54 U.S. and Japan Platelet rich plasma (PRP) market: End-use movement analysis
Fig. 55 Platelet rich plasma (PRP) market for hospitals, 2018 - 2030 (USD Million)
Fig. 56 Platelet rich plasma (PRP) market for clinics, 2018 - 2030 (USD Million)
Fig. 57 Platelet rich plasma (PRP) market for other end uses, 2018 - 2030 (USD Million)
Fig. 58 Key country dynamics
Fig. 59 U.S. Platelet Rich Plasma (PRP) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Key country dynamics
Fig. 61 Japan Platelet Rich Plasma (PRP) market estimates and forecast, 2018 - 2030 (USD Million)